[1] Lau JK, Sy RW, Corbett A, Kritharides L. Myotonic dystrophy and the heart:a systematic review of evaluation and management[J]. Int J Cardiol, 2015, 184:600-608.
[2] Udd B, Krahe R. The myotonic dystrophies:molecular, clinical, and therapeutic challenges[J]. Lancet Neurol, 2012, 11:891-905.
[3] Turner C, Hilton-Jones D. Myotonic dystrophy:diagnosis, management and new therapies[J]. Curr Opin Neurol, 2014, 27:599-606.
[4] Santoro M, Masciullo M, Silvestri G, Novelli G, Botta A.Myotonic dystrophy type 1:role of CCG, CTC and CGG interruptions within DMPK alleles in the pathogenesis and molecular diagnosis[J]. Clin Genet, 2017, 92:355-364.
[5] Heatwole C, Bode R, Johnson N, Quinn C, Martens W, McDermott MP, Rothrock N, Thornton C, Vickrey B, Victorson D, Moxley R 3rd. Patient-reported impact of symptoms in myotonic dystrophy type 1(PRISM-1)[J]. Neurology, 2012, 79:348-357.
[6] Romigi A, Albanese M, Liguori C, Placidi F, Marciani MG, Massa R. Sleep-wake cycle and daytime sleepiness in the myotonic dystrophies[J]. J Neurodegener Dis, 2013:ID692026.
[7] Yu H, Laberge L, Jaussent I, Bayard S, Scholtz S, Raoul M, Pages M, Dauvilliers Y. Daytime sleepiness and REM sleep characteristics in myotonic dystrophy:a case-control study[J].Sleep, 2011, 34:165-170.
[8] Laberge L, Bégin P, Dauvilliers Y, Beaudry M, Laforte M, Jean S, Mathieu J. A polysomnographic study of daytime sleepiness in myotonic dystrophy type 1[J]. J Neurol Neurosurg Psychiatry, 2009, 80:642-646.
[9] Dauvilliers YA, Laberge L. Myotonic dystrophy type 1, daytime sleepiness and REM sleep dysregulation[J]. Sleep Med Rev, 2012, 16:539-545.
[10] Ono S, Takahashi K, Jinnai K, Kanda F, Fukuoka Y, Kurisaki H, Mitake S, Inagaki T, Yamano T, Nagao K. Loss of serotonincontaining neurons in the raphe of patients with myotonic dystrophy:a quantitative immunohistochemical study and relation to hypersomnia[J]. Neurology, 1998, 50:535-538.
[11] Manni R, Zucca C, Martinetti M, Ottolini A, Lanzi G, Tartara A. Hypersomnia in dystrophia myotonica:a neurophysiological and immunogenetic study[J]. Acta Neurol Scand, 1991, 84:498-502.
[12] Omori Y, Kanbayashi T, Imanishi A, Tsutsui K, Sagawa Y, Kikuchi YS, Takeshima M, Yoshizawa K, Uemura S, Shimizu T.Orexin/hypocretin levels in the cerebrospinal fluid and characteristics of patients with myotonic dystrophy type 1 with excessive daytime sleepiness[J]. Neuropsychiatr Dis Treat, 2018, 14:451-457.
[13] Li J, Dong XS, Yan H, Liu YN, An P, Zhao L, Li QH, Zhang XZ, Gao ZC, Han F. Positivity analysis of human leukocyte histocompatibility antigen-DQB1^* 0602 allele in Chinese patients with narcolepsy[J]. Zhonghua Yi Xue Za Zhi, 2014, 94:763-765.[李静, 董霄松, 闫涵, 刘亚男, 安培, 赵龙, 李清华, 张晓喆, 高占成, 韩芳. 发作性睡病患者人类白细胞组织相容性抗原DQB1^*0602基因阳性率分析[J]. 中华医学杂志, 2014, 94:763-765.]
[14] Ciafaloni E, Mignot E, Sansone V, Hilbert JE, Lin L, Lin X, Liu LC, Pigeon WR, Perlis ML, Thornton CA. The hypocretin neurotransmission system in myotonic dystrophy type 1[J].Neurology, 2008, 70:226-230.
[15] Schneider-Gold C, Bellenberg B, Prehn C, Krogias C, Schneider R, Klein J, Gold R, Lukas C. Cortical and subcortical grey and white matter atrophy in myotonic dystrophies type 1 and 2 is associated with cognitive impairment,depression and daytime sleepiness[J]. PLoS One, 2015, 10:e0130352.
[16] Cabada T, Iridoy M, Jericó I, Lecumberri P, Seijas R, Gargallo A, Gomez M. Brain involvement in myotonic dystrophy type 1:a morphometric and diffusion tensor imaging study with neuropsychological correlation[J]. Arch Clin Neuropsychol, 2017, 32:401-412.
[17] Winblad S, Jensen C, Månsson JE, Samuelsson L, Lindberg C.Depression in myotonic dystrophy type 1:clinical and neuronal correlates[J]. Behav Brain Funct, 2010, 6:25.
[18] Laberge L, Dauvilliers Y, Bégin P, Richer L, Jean S, Mathieu J.Fatigue and daytime sleepiness in patients with myotonic dystrophy type 1:to lump or split[J]? Neuromuscul Disord, 2009, 19:397-402.